Cardiol Therapeutics Inc.
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
CRDL | US
Overview
Corporate Details
- ISIN(s):
- CA14161Y2006
- LEI:
- Country:
- United States of America
- Address:
- 602-2265 UPPER MIDDLE ROAD EAST, OAKVILLE
- Website:
- https://www.cardiolrx.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Cardiol Therapeutics Inc. is a clinical-stage life sciences company focused on the research and clinical development of novel anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company develops treatments for underserved cardiovascular conditions, with a primary focus on pericarditis, myocarditis, and heart failure. Its lead product candidate, CardiolRx™, is an orally administered cannabidiol solution designed to target the underlying mechanisms of inflammation and fibrosis in cardiac disease. The company's pipeline also includes preclinical candidates. Cardiol Therapeutics collaborates with international research centers and clinical experts to advance its therapeutic programs for patients with debilitating heart conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cardiol Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cardiol Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cardiol Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
